Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    4 1 1
    Investigated Drugs:
    Denmark
  • Study on Daridorexant’s Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study of Daridorexant for Treating Insomnia in Patients with Mild Cognitive Impairment and Mild to Moderate Alzheimer’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Melatonin and Low-Dose Quetiapine for Patients with Psychiatric Disorders and Insomnia

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Spain
  • Study on the Effectiveness and Safety of AV-EC2023 Tablets for Adults with Insomnia

    Not yet recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Effect of Cannabidiol (CBD) on Sleep Quality in Multiple Sclerosis Patients with Insomnia

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Neurexan for Improving Sleep in Patients with Short-Term Insomnia

    Not recruiting

    2 1 1
    Investigated Diseases:
    Germany